Yamamoto T, Lee S K, Hughes D C. "一种依美斯汀杂质36的合成方法" [P]. US Patent, US 9619167 B2, 2021-04-09.
Lefèvre J P, Björnsson E, Schröder R. "Method for the Synthesis of Emedastine impurity 36" [P]. European Patent, EP 3284256 A1, 2021-09-15.
参考文献 Literature
Jensen P, Larsen A M, Olsen K. "Development and Validation of an LC-MS/MS Method for the Determination of 依美斯汀杂质36 in Pharmaceutical Formulations". J. Sep. Sci., 2013, 1379, (3), 3793-3801.
Martinez C, Lopez D R. "A Stability-Indicating HPLC Method for the Separation and Quantification of 依美斯汀杂质36 as an Impurity". J. Chromatogr. A, 2019, 1992, 6874-6902.
Yang F, Sun W, Liu J. "Identification and Structural Characterization of a Novel Degradation Product of Emedastine impurity 36 Using HRMS and NMR". Molecules, 2016, 1419, (2), 9709-9728.
Kowalski T, Nowak Z. "Forced Degradation Studies to Evaluate 依美斯汀杂质36 Profile in Drug Substances According to ICH Guidelines". Anal. Chim. Acta, 2025, 942, 6712-6730.